Andrew L. Pecora, M.D.
Dr. Pecora is the chief medical officer of NeoStem, Inc. Leading up to its merger with NeoStem, Dr. Pecora was the chairman and chief executive officer for Progenitor Cell Therapy, LLC (PCT), now a...
View ArticleCharles Melber
In 2000, Mr. Melber experienced a heart attack that resulted in repeated hospital stays. By 2004, he had more than 30 stents placed in his heart. When he was accepted into an adult stem cell clinical...
View ArticleKeith L. March, M.D., Ph.D.
Dr. March is a professor in the departments of Medicine, Cellular and Integrative Physiology and Biomedical Engineering, Indiana University School of Medicine. He directs the Indiana Center for...
View ArticlePeter Hollands, Ph.D.
Dr. Hollands is a renowned clinical scientist, academic, and researcher in the field of reproductive medicine and cord blood stem cell technology. He is a Cambridge University alumnus and scholar. He...
View ArticleAtul R. Chugh. M.D.
Dr. Chugh completed his internship in Internal Medicine at the University of Massachusetts Medical Center followed by a residency at Rush University Medical Center in Chicago, IL. Thereafter, Dr. Chugh...
View ArticlePeter Coffey, Ph.D.
Dr. Coffey is director of the London Project to Cure Blindness and Professor of Cellular Therapy and Visual Sciences at the Institute of Opthamology, University College of London (UCL). His...
View ArticleH.E. Msgr. Ignacio Carrasco de Paula
H.E. Msgr. Carrasco de Paula is the current president of the Pontifical Academy for Life. He was ordained as a priest for the Personal Prelature of Opus Dei on August 8, 1966. He was director of the...
View ArticleFr. Nicanor Pier Giorgio Austriaco, O.P.
Fr. Austriaco is a Catholic priest in the Order of Friars Preachers, also known as the Dominicans. Born in the Philippines, he earned his Ph.D. degree in Biology from the Massachusetts Institute of...
View ArticleClaudio Bordignon, M.D.
Dr. Bordignon, MolMed’s Founder, has an established international reputation as a pioneer in gene and cell therapy and is widely known for the clinical validation of several successful gene therapy...
View ArticleHeather Abrams
Ms. Abrams was diagnosed with Hodgkin’s lymphoma in 1999 when she was 15. She was treated with standard COPP/ABVD protocol and radiation and attained remission quickly. However, in July 2000, she...
View Article
More Pages to Explore .....